Mostrar el registro sencillo del ítem
Endothelial progenitor cells as biomarkers of diabetes-related cardiovascular complications
| dc.contributor.author | Benítez Camacho, Josefa | |
| dc.contributor.author | Ballesteros, Antonio | |
| dc.contributor.author | Beltrán Camacho, Lucía | |
| dc.contributor.author | Rojas Torres, Marta | |
| dc.contributor.author | Rosal Vela, Antonio | |
| dc.contributor.author | Jiménez Palomares, Margarita | |
| dc.contributor.author | Sánchez Gomar, Ismael | |
| dc.contributor.author | Durán Ruiz, María del Carmen | |
| dc.contributor.other | Anatomía Patológica, Biología Celular, Histología, Historia de la Ciencia, Medicina Legal y Forense y Toxicología | es_ES |
| dc.contributor.other | Biomedicina, Biotecnología y Salud Pública | es_ES |
| dc.date.accessioned | 2024-03-14T12:20:29Z | |
| dc.date.available | 2024-03-14T12:20:29Z | |
| dc.date.issued | 2023-11-10 | |
| dc.identifier.issn | 1757-6512 | |
| dc.identifier.uri | http://hdl.handle.net/10498/31396 | |
| dc.description.abstract | Diabetes mellitus (DM) constitutes a chronic metabolic disease characterized by elevated levels of blood glucose which can also lead to the so-called diabetic vascular complications (DVCs), responsible for most of the morbidity, hospitalizations and death registered in these patients. Currently, different approaches to prevent or reduce DM and its DVCs have focused on reducing blood sugar levels, cholesterol management or even changes in lifestyle habits. However, even the strictest glycaemic control strategies are not always sufficient to prevent the development of DVCs, which reflects the need to identify reliable biomarkers capable of predicting further vascular complications in diabetic patients. Endothelial progenitor cells (EPCs), widely known for their potential applications in cell therapy due to their regenerative properties, may be used as differential markers in DVCs, considering that the number and functionality of these cells are affected under the pathological environments related to DM. Besides, drugs commonly used with DM patients may influence the level or behaviour of EPCs as a pleiotropic effect that could finally be decisive in the prognosis of the disease. In the current review, we have analysed the relationship between diabetes and DVCs, focusing on the potential use of EPCs as biomarkers of diabetes progression towards the development of major vascular complications. Moreover, the effects of different drugs on the number and function of EPCs have been also addressed. | es_ES |
| dc.format | application/pdf | es_ES |
| dc.language.iso | eng | es_ES |
| dc.publisher | Springer | es_ES |
| dc.rights | Atribución 4.0 Internacional | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
| dc.source | Stem Cell Research and Therapy. Vol. 14, nº 1, December 2023, 324 | es_ES |
| dc.subject | Diabetes mellitus | es_ES |
| dc.subject | Diabetic vascular complications | es_ES |
| dc.subject | Endothelial progenitor cells | es_ES |
| dc.subject | Biomarkers | es_ES |
| dc.title | Endothelial progenitor cells as biomarkers of diabetes-related cardiovascular complications | es_ES |
| dc.type | journal article | es_ES |
| dc.rights.accessRights | open access | es_ES |
| dc.description.physDesc | 24 páginas | es_ES |
| dc.identifier.doi | 10.1186/s13287-023-03537-8 | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 (ISCIII)/PI20%2F00716/ES/COMPLICACIONES VASCULARES EN DIABETES MELLITUS: APLICACION DE ESTRATEGIAS PROTEOMICAS PARA POTENCIAR EL DESARROLLO DE TERAPIAS MOLECULARES%2FCELULARES ESPECIFICAS PARA CADA PACIENTE/ | es_ES |
| dc.type.hasVersion | VoR | es_ES |
Ficheros en el ítem
Este ítem aparece en la(s) siguiente(s) colección(ones)
-
Artículos Científicos [12009]
-
Articulos Científicos Anat. Pat. [108]
-
Articulos Científicos Biomedicina [582]
